To include your compound in the COVID-19 Resource Center, submit it here.

Isis, Ercole antisense deal

The companies partnered to research and develop antisense-based compounds that regulate alternative RNA splicing.

Read the full 148 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE